After an all-night session, the Senate on Sunday passed a sweeping, $740 billion reconciliation package titled the “Inflation Reduction.” The measure passed on a party line 51-50 vote, with Vice President Kamala Harris breaking the tie vote. The 755-page bill will now be taken up by the House today, where it is expected to pass […]

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b. Published study complements KidneyIntelX clinical utility data published at American Diabetes Association Annual Conference demonstrating improvements in guideline recommended care, including therapeutic managements and specialist consultation […]

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336, an investigational small molecule inhibitor against the binding of menin and mixed-lineage leukemia (MLL) protein, for the treatment of acute myeloid leukemia (AML).  “We are pleased to have […]

PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022.

Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform

The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336.

Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses

Modern design advances patient care by combining hemostasis with innovative cooling capability